• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

性别影响经肝活检证实的非酒精性脂肪性肝病患者四肢骨骼肌与内脏脂肪面积比与非酒精性脂肪性肝炎之间的关联。

Sex influences the association between appendicular skeletal muscle mass to visceral fat area ratio and non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease.

机构信息

NAFLD Research Center, Department of Hepatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou325000, People's Republic of China.

Department of Gastroenterology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China.

出版信息

Br J Nutr. 2022 Jun 14;127(11):1613-1620. doi: 10.1017/S0007114521002415. Epub 2021 Jun 28.

DOI:10.1017/S0007114521002415
PMID:34176541
Abstract

Sarcopenic obesity is regarded as a risk factor for the progression and development of non-alcoholic fatty liver disease (NAFLD). Since male sex is a risk factor for NAFLD and skeletal muscle mass markedly varies between the sexes, we examined whether sex influences the association between appendicular skeletal muscle mass to visceral fat area ratio (SVR), that is, an index of skeletal muscle mass combined with abdominal obesity, and the histological severity of NAFLD. The SVR was measured by bioelectrical impedance in a cohort of 613 (M/F = 443/170) Chinese middle-aged individuals with biopsy-proven NAFLD. Multivariable logistic regression and subgroup analyses were used to test the association between SVR and the severity of NAFLD (i.e. non-alcoholic steatohepatitis (NASH) or NASH with the presence of any stage of liver fibrosis). NASH was identified by a NAFLD activity score ≥5, with a minimum score of 1 for each of its categories. The presence of fibrosis was classified as having a histological stage ≥1. The SVR was inversely associated with NASH in men (adjusted OR 0·62; 95 % CI 0·42, 0·92, = 0·017 for NASH, adjusted OR 0·65; 95 % CI 0·43, 0·99, = 0·043 for NASH with the presence of fibrosis), but not in women (1·47 (95 % CI 0·76, 2·83), = 0·25 for NASH, and 1·45 (95 % CI 0·74, 2·83), = 0·28 for NASH with the presence of fibrosis). There was a significant interaction for sex and SVR ( = 0·017 for NASH and = 0·033 for NASH with the presence of fibrosis). Our findings show that lower skeletal muscle mass combined with abdominal obesity is strongly associated with the presence of NASH only in men.

摘要

肌肉减少性肥胖被认为是非酒精性脂肪性肝病(NAFLD)进展和发展的一个危险因素。由于男性是 NAFLD 的一个危险因素,而且男女之间的骨骼肌质量差异显著,因此我们研究了性别是否会影响四肢骨骼肌与内脏脂肪面积比(SVR)的关系,即结合腹型肥胖的骨骼肌质量指数,与 NAFLD 的组织学严重程度之间的关系。SVR 通过生物电阻抗法在 613 名(男/女=443/170)经活检证实患有 NAFLD 的中国中年人群中进行测量。采用多变量逻辑回归和亚组分析来检验 SVR 与 NAFLD 严重程度(即非酒精性脂肪性肝炎(NASH)或 NASH 伴任何阶段的肝纤维化)之间的关系。NASH 通过 NAFLD 活动评分≥5 来确定,每个分类的最小得分为 1。纤维化的存在被分为组织学分期≥1。SVR 与男性的 NASH 呈负相关(调整后的比值比 0.62;95%可信区间 0.42,0.92, = 0.017 用于 NASH,调整后的比值比 0.65;95%可信区间 0.43,0.99, = 0.043 用于 NASH 伴纤维化),但与女性无关(1.47(95%可信区间 0.76,2.83), = 0.25 用于 NASH,和 1.45(95%可信区间 0.74,2.83), = 0.28 用于 NASH 伴纤维化)。性别和 SVR 之间存在显著的交互作用( = 0.017 用于 NASH, = 0.033 用于 NASH 伴纤维化)。我们的研究结果表明,较低的骨骼肌质量结合腹型肥胖与男性的 NASH 存在强烈相关。

相似文献

1
Sex influences the association between appendicular skeletal muscle mass to visceral fat area ratio and non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease.性别影响经肝活检证实的非酒精性脂肪性肝病患者四肢骨骼肌与内脏脂肪面积比与非酒精性脂肪性肝炎之间的关联。
Br J Nutr. 2022 Jun 14;127(11):1613-1620. doi: 10.1017/S0007114521002415. Epub 2021 Jun 28.
2
Appendicular Skeletal Muscle Mass to Visceral Fat Area Ratio Predicts Hepatic Morbidities.附肢骨骼肌质量与内脏脂肪面积比值预测肝脏疾病。
Gut Liver. 2024 May 15;18(3):509-519. doi: 10.5009/gnl230238. Epub 2023 Nov 28.
3
Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.肌肉减少症是非酒精性脂肪性肝炎和显著纤维化的独立危险因素。
J Hepatol. 2017 Jan;66(1):123-131. doi: 10.1016/j.jhep.2016.08.019. Epub 2016 Sep 4.
4
The relationship between non-alcoholic fatty liver and skeletal muscle mass to visceral fat area ratio in women with type 2 diabetes.2 型糖尿病女性患者非酒精性脂肪肝与骨骼肌质量至内脏脂肪面积比值的关系。
BMC Endocr Disord. 2019 Jul 17;19(1):76. doi: 10.1186/s12902-019-0404-1.
5
Muscle fat content is strongly associated with NASH: A longitudinal study in patients with morbid obesity.肌肉脂肪含量与 NASH 密切相关:一项对病态肥胖患者的纵向研究。
J Hepatol. 2021 Aug;75(2):292-301. doi: 10.1016/j.jhep.2021.02.037. Epub 2021 Apr 15.
6
Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease is associated with heterogeneous pattern of fat infiltration in skeletal muscles.非酒精性脂肪性肝病患者的肝细胞癌与骨骼肌内脂肪浸润的异质性模式相关。
Eur Radiol. 2024 Mar;34(3):1461-1470. doi: 10.1007/s00330-023-10131-2. Epub 2023 Sep 2.
7
The relationship between skeletal muscle mass to visceral fat area ratio and metabolic dysfunction-associated fatty liver disease subtypes in middle-aged and elderly population: a single-center retrospective study.中老年人群骨骼肌质量与内脏脂肪面积比值与代谢功能障碍相关脂肪性肝病亚型的关系:一项单中心回顾性研究
Front Nutr. 2023 Nov 8;10:1246157. doi: 10.3389/fnut.2023.1246157. eCollection 2023.
8
Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.瘦型非酒精性脂肪性肝病患者的肝脏和心血管损伤,及其与内脏肥胖的关系。
Clin Gastroenterol Hepatol. 2017 Oct;15(10):1604-1611.e1. doi: 10.1016/j.cgh.2017.04.045. Epub 2017 May 26.
9
Low skeletal muscle mass is associated with more severe histological features of non-alcoholic fatty liver disease in male.低骨骼肌量与男性非酒精性脂肪性肝病更严重的组织学特征相关。
Hepatol Int. 2022 Oct;16(5):1085-1093. doi: 10.1007/s12072-022-10384-x. Epub 2022 Jul 13.
10
Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease.FLIP算法和SAF评分在非酒精性脂肪性肝病患者中的临床验证。
J Hepatol. 2020 May;72(5):828-838. doi: 10.1016/j.jhep.2019.12.008. Epub 2019 Dec 17.

引用本文的文献

1
Body muscle mass versus fat mass: gender-specific associations with NAFLD and liver fibrosis.身体肌肉量与脂肪量:与非酒精性脂肪性肝病及肝纤维化的性别特异性关联
Lipids Health Dis. 2025 Sep 9;24(1):278. doi: 10.1186/s12944-025-02694-4.
2
Metabolic dysfunction-associated steatotic liver disease: A story of muscle and mass.代谢功能障碍相关脂肪性肝病:肌肉与体重的故事。
World J Gastroenterol. 2025 May 28;31(20):105346. doi: 10.3748/wjg.v31.i20.105346.
3
A randomized controlled trial of a weight loss maintenance program in adults with obesity: the WLM3P study.
一项针对肥胖成年人的体重维持计划的随机对照试验:WLM3P 研究。
Eur J Clin Nutr. 2024 Aug;78(8):694-702. doi: 10.1038/s41430-024-01454-4. Epub 2024 Jun 6.
4
LEARN algorithm: a novel option for predicting non-alcoholic steatohepatitis.LEARN算法:预测非酒精性脂肪性肝炎的一种新方法。
Hepatobiliary Surg Nutr. 2023 Aug 1;12(4):507-522. doi: 10.21037/hbsn-21-523. Epub 2023 Mar 30.
5
Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease.非酒精性脂肪性肝病/代谢相关脂肪性肝病中的肌少症骨量减少症:慢性肝病中一个被低估的临床问题。
Int J Mol Sci. 2023 Apr 19;24(8):7517. doi: 10.3390/ijms24087517.
6
Association between Skeletal Muscle Mass-to-Visceral Fat Ratio and Dietary and Cardiometabolic Health Risk Factors among Korean Women with Obesity.韩国肥胖女性骨骼肌质量与内脏脂肪比率与饮食和心血管代谢健康风险因素的关系。
Nutrients. 2023 Mar 24;15(7):1574. doi: 10.3390/nu15071574.
7
Sex- and region-specific associations of skeletal muscle mass with metabolic dysfunction-associated fatty liver disease.性别和区域特异性骨骼肌质量与代谢功能障碍相关脂肪性肝病的关系。
Front Endocrinol (Lausanne). 2022 Dec 2;13:1057261. doi: 10.3389/fendo.2022.1057261. eCollection 2022.
8
Appendicular Skeletal Muscle Index and HbA1c Evaluate Liver Steatosis in Patients With Metabolic Associated Fatty Liver Disease.四肢骨骼肌指数和糖化血红蛋白评估代谢相关脂肪性肝病患者的肝脏脂肪变性
Front Med (Lausanne). 2022 Jul 6;9:919502. doi: 10.3389/fmed.2022.919502. eCollection 2022.
9
rs738409 C>G Variant Influences the Association Between Visceral Fat and Significant Fibrosis in Biopsy-proven Nonalcoholic Fatty Liver Disease.rs738409 C>G变异影响经活检证实的非酒精性脂肪性肝病中内脏脂肪与显著纤维化之间的关联。
J Clin Transl Hepatol. 2022 Jun 28;10(3):439-448. doi: 10.14218/JCTH.2021.00286. Epub 2021 Oct 22.
10
Lifestyle Interventions for Non-Obese Patients Both with, and at Risk, of Non-Alcoholic Fatty Liver Disease.非肥胖非酒精性脂肪性肝病患者及高危人群的生活方式干预。
Diabetes Metab J. 2022 May;46(3):391-401. doi: 10.4093/dmj.2022.0048. Epub 2022 May 25.